Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'IIB-IIIA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1924 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lorenzo Pradelli
      Gli antagonisti del recettore GPIIb/IIIa: farmacologia, clinica ed economia nelle sindromi coronariche acute NSTEMI e nelle rivascolarizzazioni per via percutanea

      Farmeconomia e percorsi terapeutici
    2. Casterella, PJ; Kereiakes, DJ; Steinhubl, SR; Raymond, RE; Kottke-Marchant, K; Patel, K; Mueller, M; Rosenthal, M; Moliterno, DJ; Teirstein, PS
      The platelet function dose-response to abciximab during percutaneous coronary revascularization is variable

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    3. Lincoff, AM
      Anticoagulant and antiplatelet drugs

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    4. McCollam, PL; Lage, MJ; Bala, M
      A comparison of total hospital costs for percutaneous coronary intervention patients receiving abciximab versus tirofiban

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    5. Kittusamy, PK; Koenigsberg, RA; McCormick, DJ
      Abciximab for the treatment of acute distal embolization associated with internal carotid artery angioplasty

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    6. Paradiso-Hardy, FL; Madan, M; Radhakrishnan, S; Hurden, S; Cohen, EA
      Severe thrombocytopenia possibly related to readministration of eptifibatide

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    7. Lakkis, NM; George, S; Thomas, E; Ali, M; Guyer, K; Carville, D
      Use of ICHOR-platelet works to assess platelet function in patients treated with GP IIb/IIIa inhibitors

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    8. Simon, DI; Liu, CB; Ganz, P; Kirshenbaum, JM; Piana, RN; Rogers, C; Selwyn, AP; Popma, JJ
      A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    9. Chatterjee, K; Col, J; Dalby, AJ; Gulba, D
      Issues in antiplatelet therapy for UA/NSTEMI

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    10. Lopez-Sendon, J
      Coronary reperfusion in the clinical setting: antithrombotic support to thrombolysis in the coronary care unit

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    11. Braunwald, E
      Early intervention and abciximab - preserving myocardium - Proceedings of an International Symposium held in Paris, France, 23-26 May 2000 - Foreword

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    12. Montalescot, G; Choussat, R; Collet, JP
      Glycoprotein IIb/IIIa receptors and primary stenting in acute myocardial infarction

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    13. Antman, EM; de Lemos, JA; Braunwald, E
      Epicardial flow and myocardial reperfusion following abciximab and low-dose thrombolytic therapy for acute myocardial infarction

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    14. Hamm, CW
      GP IIb/IIIa receptor antagonists in unstable angina: troponin level-based patient selection

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    15. Neumann, FJ
      Optimization of microvascular reperfusion in acute myocardial infarction

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    16. Kovacs, MS; Hein, P; Sattarzadeh, S; Patrick, BO; Emge, TJ; Orvig, C
      Complexes of phosphine-phenolate ligands with the [Re=O](3+) and [Re(HNNC5H4N)(NNC5H4N)](2+) cores

      JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS
    17. Martin, GS
      The hunting of the Src

      NATURE REVIEWS MOLECULAR CELL BIOLOGY
    18. Kiefel, V
      Platelet antibodies and diagnosis of immune-mediated thrombocytopenia

      INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    19. Tomita, Y; Tanahashi, N; Tomita, M; Itoh, Y; Yokoyama, M; Takeda, H; Schiszler, I; Fukuuchi, Y
      Role of platelet glycoprotein IIb/IIIa in ADP-activated platelet adhesion to aortic endothelial cells in vitro: observation with video-enhanced contrast microscopy

      CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
    20. Inwald, D; Davies, EG; Klein, N
      Demystified ... Adhesion molecule deficiencies

      JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    21. Akkerhuis, KM; van den Brand, MJBM; van der Zwaan, C; Peels, HOJ; Suryapranata, H; van der Wieken, LR; Stibbe, J; Hoffmann, J; Baardman, T; Deckers, JW; Simoons, ML
      Pharmacodynamics and safety of lefradafiban, an oral platelet glycoproteinIIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty

      HEART
    22. Vaisman, D; Ferguson, JJ
      Therapeutic potential of GP IIb/IIIa receptor antagonists in acute myocardial infarction

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    23. Nurden, P
      The anti-GPIIb-IIIa

      TRANSFUSION CLINIQUE ET BIOLOGIQUE
    24. McKenzie, ME; Gurbel, PA
      The potential of monoclonal antibodies to reduce reperfusion injury in myocardial infarction

      BIODRUGS
    25. Deitcher, SR
      Heparin-induced thrombocytopenia: Pathogenesis, management, and prevention

      FORMULARY
    26. Schmidt, AM; Stern, DM
      Chemokines on the rise - MCP-1 and restenosis

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    27. Collett, JP; Montalescot, G; Lesty, C; Soria, J; Mishal, Z; Thoms, D; Soria, C
      Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    28. Abulencia, JP; Tien, N; McCarty, OJT; Plymire, D; Mousa, SA; Konstantopoulos, K
      Comparative antiplatelet efficacy of a novel, nonpeptide GPIIb/IIIa antagonist (XV454) and abciximab (c7E3) in flow models of thrombosis

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    29. Casonato, A; Pontara, E; Vertolli, UP; Steffan, A; Durante, C; De Marco, L; Sartorello, F; Girolami, A
      Plasma and platelet von Willebrand factor abnormalities in patients with uremia: Lack of correlation with uremic bleeding

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    30. Santillan, MKO; Herring, J; Hoppensteadt, DA; Jeske, W; Herbert, JM; Fareed, J
      The effect of a novel glycoprotein IIb/IIIa antagonist, SR 121566A, on platelet aggregation and activation in rhesus monkeys

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    31. Axelrod, DA; Wakefield, TW
      Future directions in antithrombotic therapy: Emphasis on venous thromboembolism

      JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    32. Savage, B; Cattaneo, M; Ruggeri, ZM
      Mechanisms of platelet aggregation

      CURRENT OPINION IN HEMATOLOGY
    33. Spinler, SA; Hilleman, DE; Cheng, JWM; Howard, PA; Mauro, VF; Lopez, LM; Munger, MA; Gardner, SF; Nappi, JM
      New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines

      ANNALS OF PHARMACOTHERAPY
    34. Clutton, P; Folts, JD; Freedman, JE
      Pharmacological control of platelet function

      PHARMACOLOGICAL RESEARCH
    35. Liu, S; Edwards, DS
      Stabilization of Y-90-labeled DOTA-biomolecule conjugates using gentisic acid and ascorbic acid

      BIOCONJUGATE CHEMISTRY
    36. Bogousslavsky, J; Leclerc, JR
      Platelet glycoprotein IIb/IIIa blockade in acute ischemic stroke

      CEREBROVASCULAR DISEASES
    37. Easton, JD
      Future perspectives for optimizing oral antiplatelet therapy

      CEREBROVASCULAR DISEASES
    38. Knight, LC
      Radiolabeled peptide ligands for imaging thrombi and emboli

      NUCLEAR MEDICINE AND BIOLOGY
    39. Hantgan, RR; Rocco, M; Nagaswami, C; Weisel, JW
      Binding of a fibrinogen mimetic stabilizes integrin alpha IIb beta 3's open conformation

      PROTEIN SCIENCE
    40. Manaka, A; Sato, M; Aoki, M; Tanaka, M; Ikeda, T; Toda, Y; Yamane, Y; Nakaike, S
      2-acylimino-3H-thiazoline derivatives: A novel template for platelet GPIIb/IIIa receptor antagonists

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    41. Ervin, AL; Peerschke, EIB
      Platelet activation by sustained exposure to low-dose plasmin

      BLOOD COAGULATION & FIBRINOLYSIS
    42. Phillips, DR; Prasad, KSS; Manganello, J; Bao, M; Nannizzi-Alaimo, L
      Integrin tyrosine phosphorylation in platelet signaling

      CURRENT OPINION IN CELL BIOLOGY
    43. Holmes, MB; Kabbani, SS; Terrien, CM; Watkins, MW; Sobel, BE; Schneider, DJ
      Quantification by flow cytometry of the efficacy of and interindividual variation of platelet inhibition induced by treatment with tirofiban and abciximab

      CORONARY ARTERY DISEASE
    44. Lucore, CL; Trask, RV; Mishkel, GJ; Rocha-Singh, KJ; Shelton, ME; Mikell, FL; Ligon, RW
      Impact of abciximab and coronary stenting on outcomes and costs of percutaneous coronary interventions in a community hospital

      CORONARY ARTERY DISEASE
    45. Dabadie, M; Valli, N; Jacobin, MJE; Laroche-Traineau, J; Barat, JL; Ducassou, D; Nurden, AT; Clofent-Sanchez, G
      Characterisation, cloning and sequencing of a conformation-dependent monoclonal antibody to the alpha(IIb)beta(3) integrin: interest for use in thrombus detection

      PLATELETS
    46. Eto, K; Goto, S; Shimazaki, T; Sakakibara, M; Yoshida, M; Isshiki, T; Handa, S
      Two distinct mechanisms are involved in stent thrombosis under flow conditions

      PLATELETS
    47. Haase, KK; Latsch, A; Suselbeck, T; Muth, N; Pfleger, S; Baumbach, A; Borggrefe, M
      Efficacy of eptifibatide for treatment of severe dissections following percutaneous transluminal coronary angioplasty (PTCA) in small coronary arteries

      PERFUSION
    48. Haase, KK; Koenig, W
      Clinical benefit of glycoprotein IIb/IIIa receptor antagonists in patientswith acute coronary syndrome

      PERFUSION
    49. Kereiakes, DJ; Lorenz, T; Young, JJ; Kukielka, G; Mueller, MN; Nanniazzi-Alaimo, L; Phillips, DR
      Differential effects of citrate versus PPACK anticoagulation on measured platelet inhibition by abciximab, eptifibatide and tirofiban

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    50. Matzdorff, AC; Kuhnel, G; Kemkes-Matthes, B; Voss, R
      Comparison of GP IIB/IIIA inhibitors and their activity as measured by aggregometry, flow cytometry, single platelet counting, and the rapid plateletfunction analyzer

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    51. Kimmelstiel, C; Phang, R; Rehman, A; Rand, W; Miele, R; Rhofiry, J; MacIsaac, DA; Gouveia, W; Denier, D; Becker, RC
      Short-term comparative outcomes associated with the use of GP IIb/IIIa antagonists in patients undergoing coronary intervention

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    52. Januzzi, JL; Chae, CU; Sabatine, MS; Jang, IK
      Elevation in serum troponin I predicts the benefit of tirofiban

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    53. Atar, S; Luo, H; Birnbaum, Y; Nagai, T; Siegel, RJ
      Augmentation of in-vitro clot dissolution by low frequency high-intensity ultrasound combined with antiplatelet and antithrombotic drugs

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    54. Proimos, G
      Platelet aggregation inhibition with glycoprotein IIb-IIIa inhibitors

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    55. Mukherjee, D; Chew, DP; Robbins, M; Yadav, JS; Raymond, RE; Moliterno, DJ
      Clinical application of procedural platelet monitoring during percutaneouscoronary intervention among patients at increased bleeding risk

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    56. Smith, BS; Gandhi, PJ
      Pharmacokinetics and pharmacodynamics of low-molecular-weight heparins andglycoprotein IIb/IIIa receptor antagonists in renal failure

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    57. Yassin, A; Castanet, R
      Enthalpies of dissolution of elements in liquid tin. A review III. Elements of columns IIB, IIIA, IVA, VA and VIA of the periodic table

      JOURNAL OF ALLOYS AND COMPOUNDS
    58. Mine, S; Fujisaki, T; Suematsu, M; Tanaka, Y
      Activated platelets and endothelial cell interaction with neutrophils under flow conditions

      INTERNAL MEDICINE
    59. Zhang, YH; Chung, KH; Ryu, CK; Lee, YH; Kim, TJ; Song, YS; Hwang, KA; Yun, YP
      Antiplatelet mechanism of 2-chloro-3-(4-hexylphenyl)amino-1,4-naphthoquinone (NQ304), an antithrombotic agent

      PHARMACOLOGY & TOXICOLOGY
    60. Nagahama, M; Nomura, S; Ozaki, Y; Yoshimura, C; Kagawa, H; Fukuhara, S
      Platelet activation markers and soluble adhesion molecules in patients with systemic lupus erythematosus

      AUTOIMMUNITY
    61. Missy, K; Giuriato, S; Bodin, S; Plantavid, M; Payrastre, B
      Integrins and signal transduction: illustration with the alpha(IIb)beta(3)integrin in platelets

      M S-MEDECINE SCIENCES
    62. Lin, PH; Bush, RL; Tong, FC; Chaikof, E; Martin, LG; Lumsden, AB
      Intra-arterial thrombin injection of an ascending aortic pseudoaneurysm complicated by transient ischemic attack and rescued with systemic abciximab

      JOURNAL OF VASCULAR SURGERY
    63. Anderson, KM; Califf, RM; Stone, GW; Neumann, FJ; Montalescot, G; Miller, DP; Ferguson, JJ; Willerson, JT; Weisman, HF; Topol, EJ
      Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    64. Schuhlen, H; Kastrati, A; Pache, J; Dirschinger, J; Schomig, A
      Incidence of thrombotic occlusion and major adverse cardiac events betweentwo and four weeks after coronary stent placement: Analysis of 5,678 patients with a four-week ticlopidine regimen

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    65. Neumann, FJ; Hochholzer, W; Pogatsa-Murray, G; Schomig, A; Gawaz, M
      Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    66. Lev, EI; Osende, JI; Richard, MF; Robbins, JA; Delfin, JA; Rodriguez, O; Sharma, SK; Jayasundera, T; Badimon, JJ; Marmur, JD
      Administration of abciximab to patients receiving tirofiban or eptifibatide: Effect on platelet function

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    67. Roe, MT; Ohman, EM; Maas, ACP; Christenson, RH; Mahaffey, KW; Granger, CB; Harrington, RA; Califf, RM; Krucoff, MW
      Shifting the open-artery hypothesis downstream: The quest for optimal reperfusion

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    68. Shannon, AW; Harrigan, RA
      General pharmacologic treatment of acute myocardial infarction

      EMERGENCY MEDICINE CLINICS OF NORTH AMERICA
    69. Salvati, F; Liani, M
      Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis

      INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
    70. Woods, AI; Meschengieser, SS; Blanco, AN; Salviu, MJ; Farias, CE; Kempfer, AC; Lazzari, MA
      Clinical features and laboratory patterns in a cohort of consecutive Argentinian patients with von Willebrand's disease

      HAEMATOLOGICA
    71. Rossi, F; Rossi, E; Pareti, FI; Colli, S; Tremoli, E; Gallo, L
      In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion

      HAEMATOLOGICA
    72. Keh, D; Kurer, I; Dudenhausen, JW; Woltmann, W; Falke, KJ; Gerlach, H
      Response of neonatal platelets to nitric oxide in vitro

      INTENSIVE CARE MEDICINE
    73. Auer, J; Berent, R; Maurer, E; Mayr, H; Weber, T; Eber, B
      Acute coronary syndromes - An update. Part I: Pathogenesis and drug therapy

      HERZ
    74. Goldmann, BU; Hamm, CW
      Risk stratification in acute coronary syndrome

      HERZ
    75. Schror, K
      Pathophysiology of platelet activation and pharmacology of GPIIb/IIIa antagonists

      HERZ
    76. Rendu, F; Brohard-Bohn, B; Pain, S; Bachelot-Loza, C; Auger, J
      Thiosulfinates inhibit platelet aggregation and microparticle shedding at a calpain-dependent step

      THROMBOSIS AND HAEMOSTASIS
    77. Topaz, O; Minisi, AJ; Bernardo, NL; McPherson, RA; Martin, E; Carr, SL; Carr, ME
      Alterations of platelet aggregation kinetics with ultraviolet laser emission: The "stunned platelet" phenomenon

      THROMBOSIS AND HAEMOSTASIS
    78. Derrick, JM; Shattil, SJ; Poncz, M; Gruppo, RA; Gartner, TK
      Distinct domains of alpha IIb beta 3 support different aspects of outside-in signal transduction and platelet activation induced by LSARLAF, an alphaIIb beta 3 interacting peptide

      THROMBOSIS AND HAEMOSTASIS
    79. Marques, JA; George, JK; Smith, IJ; Bhakta, V; Sheffield, WP
      A barbourin-albumin fusion protein that is slowly cleared in vivo retains the ability to inhibit platelet aggregation in vitro

      THROMBOSIS AND HAEMOSTASIS
    80. Fox, JEB
      Cytoskeletal proteins and platelet signaling

      THROMBOSIS AND HAEMOSTASIS
    81. Shattil, SJ; Leavitt, AD
      All in the family: Primary megakaryocytes for studies of platelet alpha IIb beta(3) signaling

      THROMBOSIS AND HAEMOSTASIS
    82. Woodside, DG; Liu, S; Ginsberg, MH
      Integrin activation

      THROMBOSIS AND HAEMOSTASIS
    83. Coller, BS
      Anti-GPIIb/IIIa drugs: Current strategies and future directions

      THROMBOSIS AND HAEMOSTASIS
    84. Sassoli, PM; Emmell, EL; Tam, SH; Trikha, M; Zhou, Z; Jordan, RE; Nakada, MT
      7E3 F(ab ')(2), an effective antagonist of rat alpha IIb beta 3 and alpha v beta 3, blocks in vivo thrombus formation and in vitro angiogenesis

      THROMBOSIS AND HAEMOSTASIS
    85. Savi, P; Zamboni, G; Rescanieres, O; Herbert, JM
      Studies on the binding of H-3-SR121566, an inhibitor of Gp IIb-IIIa activation

      THROMBOSIS AND HAEMOSTASIS
    86. Bennett, JS; Mousa, S
      Platelet function inhibitors in the year 2000

      THROMBOSIS AND HAEMOSTASIS
    87. Marciniak, SJ; Jordan, RE; Mascelli, MA
      Effect of Ca2+ chelation on the platelet inhibitory ability of the GPIIb/IIIa antagonists abciximab, eptifibatide and tirofiban

      THROMBOSIS AND HAEMOSTASIS
    88. Vallar, L; Regnault, V; Latger-Cannard, V; Lecompte, T
      beta(2)-glycoprotein I binding to platelet microparticle membrane specifically reduces immunoreactivity of glycoproteins IIb/IIIa

      THROMBOSIS AND HAEMOSTASIS
    89. Kosugi, S; Tomiyama, Y; Honda, S; Kashiwagi, H; Shiraga, M; Tadokoro, S; Kiyoi, T; Kurata, Y; Matsuzawa, Y
      Anti-alpha(v)beta(3) antibodies in chronic immune thrombocytopenic purpura

      THROMBOSIS AND HAEMOSTASIS
    90. Israels, SJ; McMillan-Ward, EM; Easton, J; Robertson, C; McNicol, A
      CD63 associates with the alpha(IIb)beta(3) integrin-CD9 complex on the surface of activated platelets

      THROMBOSIS AND HAEMOSTASIS
    91. Klinkhardt, U; Graff, J; Westrup, D; Kirchmaier, CM; Esslinger, HU; Breddin, HK; Harder, S
      Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    92. Graff, J; Andries, D; Elsner, M; Westrup, D; Bassus, S; Franz, N; Klinkhardt, U; Harder, S
      Platelet CD62 expression and PDCFAB secretion in patients undergoing PTCA and treatment with abciximab

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    93. Chun, D; Gall, CM; Bi, X; Lynch, G
      Evidence that integrins contribute to multiple stages in the consolidationof long term potentiation in rat hippocampus

      NEUROSCIENCE
    94. Dopheide, SM; Yap, CL; Jackson, SP
      Dynamic aspects of platelet adhesion under flow

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    95. Rodriguez-Calvillo, M; Gabari, I; Duarte, M; Mazzolini, G; Rifon, J; Rocha, E; Prieto, J; Melero, I
      Thrombopenic purpura induced by a monoclonal antibody directed to a 35-kilodalton surface protein (p35) expressed on murine platelets and endothelialcells

      EXPERIMENTAL HEMATOLOGY
    96. Schmitt, A; Guichard, J; Masse, JM; Debili, N; Cramer, EM
      Of mice and men: Comparison of the ultrastructure of megakaryocytes and platelets

      EXPERIMENTAL HEMATOLOGY
    97. Boudreaux, MK; Lipscomb, DL
      Clinical, biochemical, and molecular aspects of Glanzmann's thrombastheniain humans and dogs

      VETERINARY PATHOLOGY
    98. Galeote, G; Pastor, AA; Carcamo, C; Sobrino, N; Calvo, L; Munoz, SG; Hussein, M; Fernandez-Chacon, JL; Sobrino, JA
      Variable response to the biological inhibition of platelets by abciximab in patients subjected to percutaneous coronary angioplasty

      REVISTA ESPANOLA DE CARDIOLOGIA
    99. Cokkinos, DV
      The treatment of coronary heart disease: An update - Part 4: Acute ischaemic coronary syndromes

      CURRENT MEDICAL RESEARCH AND OPINION
    100. Nordt, TK; Bode, C
      Editorial: optimal thrombolysis

      ZEITSCHRIFT FUR KARDIOLOGIE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 13/08/20 alle ore 10:55:28